Selected research
Industry Research
Artificial Saliva Industry Research Report 2026
Market perspective
The global Artificial Saliva market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Artificial Saliva is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Artificial Saliva is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Artificial Saliva is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Artificial Saliva include GlaxoSmithKline, Fresenius Kabi, Perrigo, Parnell Pharmaceuticals, Laboratorios Kin, Icpa Health Products LTD., Forward Science, Entod International and Cipla Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Artificial Saliva market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Artificial Saliva Market by Company
GlaxoSmithKline
Fresenius Kabi
Perrigo
Parnell Pharmaceuticals
Laboratorios Kin
Icpa Health Products LTD.
Forward Science
Entod International
Cipla Limited
Biocosmetics Laboratories
Artificial Saliva Segment by Type
Gel
Oral Spray
Oral Liquid
Oral Solution
Powder
Artificial Saliva Segment by Application
Adult
Paediatric
Artificial Saliva Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Saliva market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Artificial Saliva and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Saliva.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Artificial Saliva manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Artificial Saliva by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Artificial Saliva in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gel
- Oral Spray
- Oral Liquid
- Oral Solution
- Powder
Applications
- Adult
- Paediatric
Companies covered
- GlaxoSmithKline
- Fresenius Kabi
- Perrigo
- Parnell Pharmaceuticals
- Laboratorios Kin
- Icpa Health Products LTD.
- Forward Science
- Entod International
- Cipla Limited
- Biocosmetics Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Artificial Saliva Market Size (2021-2032)
- 2.2.2 Global Artificial Saliva Sales (2021-2032)
- 2.2.3 Global Artificial Saliva Market Average Price (2021-2032)
- 2.3 Artificial Saliva by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Gel
- 2.3.3 Oral Spray
- 2.3.4 Oral Liquid
- 2.3.5 Oral Solution
- 2.3.6 Powder
- 2.4 Artificial Saliva by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adult
- 2.4.3 Paediatric
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Artificial Saliva Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Artificial Saliva Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Artificial Saliva Revenue of Manufacturers (2021-2026)
- 3.4 Global Artificial Saliva Average Price by Manufacturers (2021-2026)
- 3.5 Global Artificial Saliva Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Artificial Saliva, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Artificial Saliva, Product Type & Application
- 3.8 Global Manufacturers of Artificial Saliva, Established Date
- 3.9 Global Artificial Saliva Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GlaxoSmithKline
- 4.1.1 GlaxoSmithKline Company Information
- 4.1.2 GlaxoSmithKline Business Overview
- 4.1.3 GlaxoSmithKline Artificial Saliva Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 GlaxoSmithKline Artificial Saliva Product Portfolio
- 4.1.5 GlaxoSmithKline Recent Developments
- 4.2 Fresenius Kabi
- 4.2.1 Fresenius Kabi Company Information
- 4.2.2 Fresenius Kabi Business Overview
- 4.2.3 Fresenius Kabi Artificial Saliva Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Fresenius Kabi Artificial Saliva Product Portfolio
- 4.2.5 Fresenius Kabi Recent Developments
- 4.3 Perrigo
- 4.3.1 Perrigo Company Information
- 4.3.2 Perrigo Business Overview
- 4.3.3 Perrigo Artificial Saliva Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Perrigo Artificial Saliva Product Portfolio
- 4.3.5 Perrigo Recent Developments
- 4.4 Parnell Pharmaceuticals
- 4.4.1 Parnell Pharmaceuticals Company Information
- 4.4.2 Parnell Pharmaceuticals Business Overview
- 4.4.3 Parnell Pharmaceuticals Artificial Saliva Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Parnell Pharmaceuticals Artificial Saliva Product Portfolio
- 4.4.5 Parnell Pharmaceuticals Recent Developments
- 4.5 Laboratorios Kin
- 4.5.1 Laboratorios Kin Company Information
- 4.5.2 Laboratorios Kin Business Overview
- 4.5.3 Laboratorios Kin Artificial Saliva Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Laboratorios Kin Artificial Saliva Product Portfolio
- 4.5.5 Laboratorios Kin Recent Developments
- 4.6 Icpa Health Products LTD.
- 4.6.1 Icpa Health Products LTD. Company Information
- 4.6.2 Icpa Health Products LTD. Business Overview
- 4.6.3 Icpa Health Products LTD. Artificial Saliva Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Icpa Health Products LTD. Artificial Saliva Product Portfolio
- 4.6.5 Icpa Health Products LTD. Recent Developments
- 4.7 Forward Science
- 4.7.1 Forward Science Company Information
- 4.7.2 Forward Science Business Overview
- 4.7.3 Forward Science Artificial Saliva Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Forward Science Artificial Saliva Product Portfolio
- 4.7.5 Forward Science Recent Developments
- 4.8 Entod International
- 4.8.1 Entod International Company Information
- 4.8.2 Entod International Business Overview
- 4.8.3 Entod International Artificial Saliva Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Entod International Artificial Saliva Product Portfolio
- 4.8.5 Entod International Recent Developments
- 4.9 Cipla Limited
- 4.9.1 Cipla Limited Company Information
- 4.9.2 Cipla Limited Business Overview
- 4.9.3 Cipla Limited Artificial Saliva Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Cipla Limited Artificial Saliva Product Portfolio
- 4.9.5 Cipla Limited Recent Developments
- 4.10 Biocosmetics Laboratories
- 4.10.1 Biocosmetics Laboratories Company Information
- 4.10.2 Biocosmetics Laboratories Business Overview
- 4.10.3 Biocosmetics Laboratories Artificial Saliva Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Biocosmetics Laboratories Artificial Saliva Product Portfolio
- 4.10.5 Biocosmetics Laboratories Recent Developments
5 Global Artificial Saliva Market Scenario by Region
- 5.1 Global Artificial Saliva Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Artificial Saliva Sales by Region: 2021-2032
- 5.2.1 Global Artificial Saliva Sales by Region: 2021-2026
- 5.2.2 Global Artificial Saliva Sales by Region: 2027-2032
- 5.3 Global Artificial Saliva Revenue by Region: 2021-2032
- 5.3.1 Global Artificial Saliva Revenue by Region: 2021-2026
- 5.3.2 Global Artificial Saliva Revenue by Region: 2027-2032
- 5.4 North America Artificial Saliva Market Facts & Figures by Country
- 5.4.1 North America Artificial Saliva Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Artificial Saliva Sales by Country (2021-2032)
- 5.4.3 North America Artificial Saliva Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Artificial Saliva Market Facts & Figures by Country
- 5.5.1 Europe Artificial Saliva Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Artificial Saliva Sales by Country (2021-2032)
- 5.5.3 Europe Artificial Saliva Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Artificial Saliva Market Facts & Figures by Country
- 5.6.1 Asia Pacific Artificial Saliva Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Artificial Saliva Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Artificial Saliva Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Artificial Saliva Market Facts & Figures by Country
- 5.7.1 South America Artificial Saliva Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Artificial Saliva Sales by Country (2021-2032)
- 5.7.3 South America Artificial Saliva Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Artificial Saliva Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Artificial Saliva Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Artificial Saliva Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Artificial Saliva Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Artificial Saliva Sales by Type (2021-2032)
- 6.1.1 Global Artificial Saliva Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Artificial Saliva Sales Market Share by Type (2021-2032)
- 6.2 Global Artificial Saliva Revenue by Type (2021-2032)
- 6.2.1 Global Artificial Saliva Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Artificial Saliva Revenue Market Share by Type (2021-2032)
- 6.3 Global Artificial Saliva Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Artificial Saliva Sales by Application (2021-2032)
- 7.1.1 Global Artificial Saliva Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Artificial Saliva Sales Market Share by Application (2021-2032)
- 7.2 Global Artificial Saliva Revenue by Application (2021-2032)
- 7.2.1 Global Artificial Saliva Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Artificial Saliva Revenue Market Share by Application (2021-2032)
- 7.3 Global Artificial Saliva Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Artificial Saliva Value Chain Analysis
- 8.1.1 Artificial Saliva Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Artificial Saliva Production Mode & Process
- 8.2 Artificial Saliva Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Artificial Saliva Distributors
- 8.2.3 Artificial Saliva Customers
9 Global Artificial Saliva Analyzing Market Dynamics
- 9.1 Artificial Saliva Industry Trends
- 9.2 Artificial Saliva Industry Drivers
- 9.3 Artificial Saliva Industry Opportunities and Challenges
- 9.4 Artificial Saliva Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst